Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Oct;93(10):3870-7.
doi: 10.1210/jc.2008-0021. Epub 2008 Jul 29.

Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample

Affiliations

Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample

Susan A Hall et al. J Clin Endocrinol Metab. 2008 Oct.

Abstract

Context: Risk factors for low testosterone and symptomatic androgen deficiency (AD) may be modifiable.

Objective: Our objective was to examine demographic, anthropometric, and medical correlates of low testosterone and symptomatic AD.

Design: Data were used from the Boston Area Community Health Survey, an epidemiological study conducted from 2002-2005.

Setting: Data were obtained from a community-based random sample of racially and ethnically diverse men.

Patients or other participants: Data were available for 1822 men.

Main outcome measures: Multivariate logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI) for associations of covariates with 1) low testosterone and 2) symptomatic AD. The operational definition of low testosterone was serum total testosterone less than 300 ng/dl and free testosterone less than 5 ng/dl; symptomatic AD was defined as the additional presence of symptoms: any of low libido, erectile dysfunction, or osteoporosis or two or more of sleep disturbance, depressed mood, lethargy, or diminished physical performance.

Results: Factors associated with low testosterone included age (OR = 1.36; 95% CI= 1.11-1.66, per decade), low per-capita income ($6000 or less per household member vs. more than $30,000; OR = 2.86; 95% CI = 1.39-5.87), and waist circumference (per 10-cm increase; OR = 1.75; 95% CI = 1.45-2.12). Only age (OR = 1.36; 95% CI = 1.04-1.77), waist circumference (OR = 1.88; 95% CI = 1.44-2.47), and health status (OR = 0.21; 95% CI = 0.05-0.92, excellent vs. fair/poor) were associated with our construct of symptomatic AD. Of all variables, waist circumference was the most important contributor in both models.

Conclusions: Waist circumference is a potentially modifiable risk factor for low testosterone and symptomatic AD. Manifestation of symptoms may be a consequence of generally poor health status.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Information provided by variables in multivariate models for low total and free testosterone. The model containing all the relevant variables from submodels accounted for a total of 18.4% of information compared with a theoretical model containing all possible predictors (as measured by the deviance R2). The proportionate contribution of covariate groups are depicted at the right. Covariate groups were added one at a time (from highest contributor to lowest). Of the contributing groups, the body composition group containing the variable for waist circumference was by far the most important.
Figure 2
Figure 2
Information provided by variables in multivariate models for symptomatic AD. The model containing all the relevant variables from submodels accounted for a total of 25.0% of information compared with a theoretical model containing all possible predictors (as measured by the deviance R2).The proportionate contribution of covariate groups are depicted at the right. Covariate groups were added one at a time (from highest contributor to lowest). Of the contributing groups, the body composition group containing the variable for waist circumference was once again the most important.

Similar articles

Cited by

References

    1. US Department of Health and Human Services 2003 National Health and Nutrition Examination Survey data briefs: healthy weight, overweight, and obesity among U.S. adults. Atlanta, GA: Centers for Disease Control and Prevention
    1. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM 2006 Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 91:1995–2010 - PubMed
    1. Kaufman JM, Vermeulen A 2005 The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 26:833–876 - PubMed
    1. Wong SY, Chan DC, Hong A, Woo J 2006 Prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong. Metabolism 55:1488–1494 - PubMed
    1. Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C 2006 Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 60:762–769 - PMC - PubMed

Publication types

MeSH terms